BIIB 722 Mesylate

CAS No. 261505-81-1

BIIB 722 Mesylate( —— )

Catalog No. M37367 CAS No. 261505-81-1

BIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BIIB 722 Mesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    BIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.
  • Description
    BIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    261505-81-1
  • Formula Weight
    504.483
  • Molecular Formula
    C19H23F3N6O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC(=N)N)C1=CC=C(C(=C1)C(F)(F)F)N2CCN(C(=O)C3=CC=CN3)CC2.O=S(=O)(O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Mepivacaine hydrochl...

    Mepivacaine is a tertiary amine used as a local anesthetic.

  • DPI 201-106

    DPI 201-106 is a cardioselective inhibitor of the TTX-resistant h1 Na channel inactivation resulting in a positive inotropic effect.

  • AZ194

    CRMP2-Ubc9-NaV1.7 inhibitor 194, is a CRMP2-Ubc9-NaV1.7 inhibitor.